Latest Health News
- FDA OKs New Treatment for Hard-to-Treat Lung CancerThe FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.
- Why ‘Healthy’ Food Labels Fool Even Savvy ShoppersEvery time you visit the grocery store, your brain is absorbing countless food-packaging cues. Those cues influence your choices more than you think.
- Why Mounjaro Tops Ozempic for Weight LossIn the first head-to-head trial of its kind, people with obesity who took tirzepatide (sold under the brand names Mounjaro and Zepbound) lost more weight and inches from their waist than those who took semaglutide (Ozempic, Wegovy).
- Living Near a Golf Course Linked to Parkinson’s. What to DoPesticides used to maintain the greens could be polluting your drinking water, researchers say. A few simple tips could help you minimize your exposure.
- FDA Approves New Oral Drug Combo for Rare Ovarian CancerThe treatment includes two drugs known as avutometinib and defactinib and is marketed as Avmapki Fakzynja Co-Pack.
- Doctors Share Mothers’ Health TipsWith Mother’s Day approaching, we asked five top doctors for maternal health tips that showed just how smart their moms really were.
- CT Scans and Radiation Risk: What to Say to Your DoctorDeciding whether to get a CT scan is up to you. But it helps to know some context and details, and the right questions to ask your doctor.
- How the Bird Flu Could Quickly Turn Into a PandemicMore than a year after bird flu jumped to cattle, scientists are focused on two big questions: Could bird flu become a pandemic? And how can we stop that from happening?
- Science Reveals 4 New Ways to Lower Your Dementia RiskThe mind-body connection is huge in dementia research now. Here are the latest evidence-backed ways to boost your physical health while also lowering your risk of dementia.
- How to Accept When Stress Is Too Much (and What to Do Next)More evidence links poor health with "allostatic overload," the cumulative toll of chronic stress on your body. The good news: You can prevent it – or find your way out from under it.
- FDA Approves New Long-Term Treatment for Myasthenia GravisThe FDA approves Imaavy, a groundbreaking treatment for generalized myasthenia gravis (gMG), offering symptom relief and reduced autoantibody levels in adults and children over 12.
- Study Links Plastics to 350K Heart Deaths – But Is It Accurate?A new study suggests that 350,000 heart-related deaths may be due in part to exposure to high levels of phthalates – chemicals used to soften plastic. But read more to learn about this study's limits.
- FDA Approves New Gene Therapy for Rare Genetic Skin DisorderThe FDA has approved a treatment called prademagene zamikeracel (sold as Zevaskyn), as a gene therapy for people with a rare genetic skin disorder known as recessive dystrophic epidermolysis bullosa (RDEB).
- This New Treatment Is Transforming Prostate Cancer CareTheranostics – an approach that combines the power of radiotherapy with diagnostics – is changing how we treat prostate cancer, especially in advanced stages.
- Will Ultra-Processed Foods Kill You? 5 Findings From a New StudyA new global study suggests that a diet high in things like soda, packaged snacks, and frozen meals – products that have been highly processed and often contain additives – could shave years off your life.
- Will Food Dye Bans Really Make Your Diet Healthier?Artificial food dyes are in the government's crosshairs, with plans to ban all eight of them by the end of 2026. Here's what that means for you and your health.
- How Your Oral Microbiome Could Be Triggering Your MigrainesResearchers have uncovered clues linking the oral microbiome to migraine headaches, posing opportunities for new interventions.
- New Study Says Measles Could Become Endemic: 3 Key TakeawaysAs U.S. measles cases rise, a study suggests the disease could become endemic again – meaning bigger than an outbreak but not quite as big as a pandemic.
- FDA OKs New Drug for Rare Head and Neck CancerThe FDA has approved a new drug for adults with a rare type of head and neck cancer known as non-keratinizing nasopharyngeal carcinoma (NPC).
- The 15-Year Aging Advantage You Can Start Building TodayA new study suggests that people with good "immune resilience" – the ability to stay healthy and bounce back after infections like the flu – have a 15-year survival advantage over those whose resilience starts to falter.
- New Science Reveals How to Quit Vaping – and Stick With ItNew research shows that treatment using medication, counseling, and a supportive text messaging app can help young people quit vaping for good.
- Tick Season Is Back, but New Lyme Treatment Is on the Horizon Lyme disease could be worse than ever this year, but two new studies are offering hope.
- New Study Links Cannabis and Dementia. Here’s What That MeansCannabis users who visited the emergency room or were hospitalized were up to four times as likely as people in the general population to be diagnosed with dementia within five years, a large new study shows.
- FDA Approves Dupixent for Chronic Skin ConditionThe FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular allergy meds don't do the trick.
- We May Soon Have a Blood Test to Predict Postpartum DepressionThe innovative advance could shift treatment from response to prevention, and redefine how we think about this common maternal condition.
Recommended